|
- 2018
Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexateKeywords: biologic, claims, methotrexate, tumor necrosis factor Abstract: The objective of this study was to assess the treatment for patients with rheumatoid arthritis (RA) in the USA
|